Clinical Trial Update: Extensively Hydrolyzed Formula: Hypoallergenicity [NA]

View source ↗

Summary

Completed clinical trial evaluating hypoallergenicity of an extensively hydrolyzed infant formula sponsored by Nestlé SPN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Hypersensitivity

Drugs mentioned

• Extensively Hydrolyzed Formula

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Food Hypersensitivity | NA | Status: COMPLETED